Goldline Pharmaceutical IPO GMP History & Listing Result
The last grey market premium recorded for Goldline Pharmaceutical SME IPO before listing, on 18 May 2026, 02:48 pm IST, was +₹15 (+34.9% over the issue price), implying a listing around ₹58 per share. Goldline Pharmaceutical listed at ₹59.75 (+38.95% versus the issue price) on May 19, 2026.
IPO Details
| Status | Listed |
| Type | SME |
| Open Date | May 12, 2026 |
| Close Date | May 14, 2026 |
| Listing Date | May 19, 2026 |
| Issue Size | ₹12.00 Cr |
GMP Trend
How Goldline Pharmaceutical’s GMP moved
| Date | GMP | % of issue price | |
|---|---|---|---|
| First quote | 08 May 2026 | ₹6 | +14% |
| Highest | 13 May 2026 | ₹25 | +58.1% |
| Lowest | 08 May 2026 | ₹0 | +0% |
| Last before listing | 18 May 2026 | ₹15 | +34.9% |
Quoted on 9 days; the premium changed 11 times between readings.
The last GMP pointed to a listing near ₹58; the shares opened at ₹59.75 — a miss of 2.9%, and the direction was right. Across 117 SME IPOs we have measured, the average miss is 9.8%.
GMP History
| Date | GMP (Rs) | Change | GMP % | Est. Listing |
|---|---|---|---|---|
| May 18, 2026 02:48 pm | +15 | ▼ 2 | +34.9% | ₹58 |
| May 16, 2026 06:41 am | +17 | ▲ 2 | +39.5% | ₹60 |
| May 14, 2026 05:20 pm | +15 | ▼ 10 | +34.9% | ₹58 |
| May 13, 2026 05:07 pm | +25 | ▲ 11 | +58.1% | ₹68 |
| May 13, 2026 04:39 pm | +14 | ▼ 4 | +32.6% | ₹57 |
| May 12, 2026 08:03 pm | +18 | ▲ 1 | +41.9% | ₹61 |
| May 11, 2026 07:28 pm | +17 | ▲ 1 | +39.5% | ₹60 |
| May 11, 2026 02:02 pm | +16 | ▲ 1 | +37.2% | ₹59 |
| May 10, 2026 08:49 am | +15 | ▲ 7 | +34.9% | ₹58 |
| May 09, 2026 10:23 am | +8 | ▲ 2 | +18.6% | ₹51 |
| May 08, 2026 04:30 pm | +6 | ▲ 6 | +14.0% | ₹49 |
| May 08, 2026 12:30 pm | +0 | — | +0.0% | ₹43 |
Other IPO GMP Today
View all →Goldline Pharmaceutical IPO GMP — Detailed Analysis
What Goldline Pharmaceutical GMP Said Before Listing
The last Grey Market Premium recorded for Goldline Pharmaceutical IPO was Rs 15 (34.9% over the issue price). Based on this GMP, the implied listing price was around Rs 58 per share. Across the 12 GMP records captured for this issue, the trend was rising by Rs 15 before listing. Goldline Pharmaceutical listed at Rs 59.75 (+38.95% versus the issue price) on May 19, 2026.
Goldline Pharmaceutical IPO listed on May 19, 2026.
Goldline Pharmaceutical IPO GMP — FAQs
New to grey market data? The hub covers how to read a GMP trend and how SME GMP compares with actual listing performance, and our explainer goes deeper: What is IPO GMP?